top of page
Lecture 15: Endotheliopathy of Long COVID
Etheresia Pretorius PhD
Presentation Date:
January 16, 2025

Etheresia Pretorius PhD
Stellenbosch University, South Africa
resiap@sun.ac.za
> Funding: Polybio Research Foundation (USA), Balvi Research Foundation (USA, KERNLS crowd funding initiative, MRC and NRF (South Africa), StandingUpToPOTS (USA)
> A founding director of Biocode Technologies.
> Five years ago, in early 2020, we all became aware of a new pandemic, COVID-19.
> It quickly became apparent that in some patients the virus was associated with a severe coagulopathy, resulting in significant morbidity and mortality.
> Emerging evidence has indicated that coagulation changes play a major role in the pathophysiology of COVID, particularly Long-COVID, the persistent symptoms following infection.
> In this presentation, Dr. Resia Pretorius discusses use of cutting edge laboratory studies in coagulation and vascular biology, as it applies to COVID.

Left: a standard rendering of the COVID-19 virus
No Lecture, Winter Holiday Break
Starting in 2025, lectures are eligible for Continuing Education Credit.
Link for CE:
bottom of page